Urolithin A vs Curcumin
Urolithin A and curcumin are two of the most talked-about plant-derived compounds in the longevity and recovery space, but they work through genuinely different biology. One helps your cells recycle worn-out machinery; the other helps steady the body's antioxidant and inflammatory tone. Understanding that distinction is the fastest way to decide whether either belongs in your routine.
Both compounds start life in colorful plant foods, and both have moved from folklore into the laboratory. But they are not interchangeable, and they are not competitors in the way marketing sometimes implies. This guide walks through what each one actually is, how the mechanisms diverge, what human evidence supports and what remains preclinical, and how thoughtful people combine or choose between them. For the full background on the first compound, see our urolithin A guide.
Two different jobs inside the cell
Curcumin is the bright yellow pigment in turmeric root. It has been studied for decades primarily as an antioxidant and as a modulator of inflammatory signaling - it interacts with pathways such as NF-kB and influences the activity of enzymes tied to the body's inflammatory response. In simple terms, curcumin is best understood as a compound that helps the body maintain a balanced inflammatory and oxidative tone rather than one that rebuilds cellular hardware.
Urolithin A does something structurally different. It is a gut postbiotic: your microbiome produces it from ellagitannins, the large polyphenols found in pomegranate, walnuts, and certain berries. Only some people carry the gut bacteria needed to make meaningful amounts, which is one reason supplementation exists at all. Once absorbed, urolithin A supports a housekeeping process called mitophagy - the cell's way of identifying worn or damaged mitochondria and recycling them so fresher, more efficient ones can take their place. Mitochondria are the structures that turn food and oxygen into usable energy, and their quality tends to decline with age. To go deeper on that renewal process, see what is mitophagy and mitochondrial health.
So the headline contrast is this: curcumin works largely as an antioxidant and inflammatory-balance compound, while urolithin A works upstream on the quality control of your energy-producing machinery. They are addressing different layers of the same broad goal - cells that function well as you age.
The human evidence, side by side
Urolithin A: proven human findings first
The urolithin A human record is young but unusually well organized for a supplement ingredient. The first-in-human trial, Andreux and colleagues in 2019 (Nature Metabolism), established that urolithin A was safe and well tolerated at doses up to 1,000 mg per day and produced a measurable shift in mitochondrial gene expression in older adults. That safety-and-signal foundation is what made the later performance trials worth running.
Two randomized controlled trials then looked at muscle. Liu, D'Amico and colleagues (2022, JAMA Network Open) studied older adults over roughly four months and reported improvements in muscle endurance. Singh and colleagues (2022, Cell Reports Medicine) studied middle-aged adults over four months with 500 mg and 1,000 mg arms and reported benefits to muscle strength and exercise performance. More recent human work has extended the picture: a 2024 randomized trial in the Journal of the International Society of Sports Nutrition looked at resistance-trained men over eight weeks, a 2025 trial examined distance runners, and a 2025 study in Nature Aging (a roughly 28-day RCT) reported support for immune-cell mitochondrial health in midlife adults - a line of research tied to so-called inflammaging. For a plain-language walk-through of these trials, see urolithin A clinical studies.
Curcumin: a broader but noisier human record
Curcumin has been studied in humans far longer and across a wide range of endpoints. GRADE-assessed systematic reviews and dose-response meta-analyses of randomized trials have reported that curcumin or turmeric supplementation can favorably influence markers associated with antioxidant status and inflammatory balance in adults. The caveat researchers repeatedly raise is bioavailability: plain curcumin is poorly absorbed and rapidly metabolized, which is why many formulations add piperine (black pepper extract) or use specialized delivery systems. The breadth of curcumin research is a strength, but the variability in formulations, doses, and study quality means findings are less tidy than the compact urolithin A trial set.
The honest summary: curcumin has more total human studies but more heterogeneity, while urolithin A has fewer studies but a cleaner, more consistent thread around muscle and mitochondrial endpoints. A 2024 systematic review in Ageing Research Reviews on targeting aging with urolithin A in humans put it plainly - the evidence is still emerging.
What is still preclinical for each
Both compounds carry a tail of exciting early research that should be read as hypothesis, not proof. For urolithin A, the foundational mechanism work is preclinical: Ryu and colleagues (2016, Nature Medicine) demonstrated mitophagy, extended lifespan in the worm C. elegans, and improved muscle measures in rodents. D'Amico and colleagues (2022, Aging Cell) explored joint and cartilage outcomes in osteoarthritis models - again, preclinical. Areas such as skin, gut, brain, and heart remain at the early or preclinical stage where research is still exploring possibilities.
Curcumin has its own large preclinical literature spanning many organ systems and cell models. As with urolithin A, animal and test-tube findings do not automatically translate to people, and dramatic laboratory effects often shrink or disappear in well-controlled human trials. Treating the preclinical material as a map of open questions - rather than a list of benefits - is the disciplined way to read both compounds.
Practical guidance: choosing or combining
If your priority is energy and muscle as you age
Urolithin A is the more targeted choice, because the human trials that exist cluster specifically around muscle endurance, strength, and mitochondrial measures. The studied dose is 500 to 1,000 mg per day, with 1,000 mg at the top of that range. Benefits in the trials accrued over weeks to months, not days - see how long urolithin A takes to work for realistic timelines, and urolithin A for muscle for the strength-and-recovery angle.
If your priority is inflammatory and antioxidant balance
Curcumin has the longer track record here, provided you choose a formulation designed for absorption. It is a reasonable option for people focused on general antioxidant support rather than mitochondrial renewal specifically.
Can you take both?
Because the mechanisms are largely non-overlapping - recycling machinery versus buffering oxidative and inflammatory tone - there is no obvious biological conflict in using both, and many people do. That said, no human trial has tested this specific combination for added benefit, so any stacking rationale is theoretical. Neither compound is a treatment for any disease, and neither replaces medical care. If you take medications - curcumin in particular can interact with blood thinners and some other drugs - or have a health condition, this is a decision to make with your doctor, not from a label. This guidance is educational and is not a substitute for individualized medical advice.
Frequently asked questions
Is urolithin A better than curcumin?
Neither is universally better - they do different jobs. Urolithin A supports mitophagy, the recycling of worn mitochondria, and its human trials focus on muscle and mitochondrial measures. Curcumin acts more as an antioxidant and inflammatory-balance compound with a longer but noisier human record. The right choice depends on your goal.
Can I take urolithin A and curcumin together?
Their mechanisms are largely separate, so there is no obvious conflict, and many people combine them. However, no human study has tested the specific combination for added benefit, so the rationale is theoretical. Curcumin can interact with certain medications, so check with your doctor first.
Does turmeric contain urolithin A?
No. Urolithin A is not found in turmeric. It is made by gut bacteria from ellagitannins in pomegranate, walnuts, and berries. Turmeric supplies curcumin, a completely different compound. See foods high in urolithin A for dietary sources of the precursors.
Why do people supplement urolithin A instead of eating pomegranate?
Only some people carry the gut bacteria needed to convert ellagitannins into meaningful amounts of urolithin A. Supplementing delivers the finished compound directly, bypassing that variability. The human trials used 500 to 1,000 mg per day, an amount difficult to reach through diet alone.
Which one has stronger human evidence?
Curcumin has more total human studies but with wide variation in formulation and quality. Urolithin A has fewer studies but a more consistent thread around muscle and mitochondrial endpoints. A 2024 systematic review described the urolithin A human evidence as still emerging.
Are these compounds a treatment for inflammation or aging?
No. Both are studied for structure and function support only. Neither is intended to diagnose, treat, cure, or prevent any disease, and neither reverses aging. If you have a health concern, see your doctor.
What dose of urolithin A is worth considering?
Human trials studied 500 to 1,000 mg per day, with 1,000 mg at the top of the range. For a fuller discussion see urolithin A dosage and best urolithin A gummies.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.
A clinically studied 1,000 mg dose of Urolithin A in one simple daily gummy — to support mitophagy, muscle strength, and cellular energy.
Shop SOMA Urolithin A Gummies →